LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

Home・Aandelen Lijst・Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings Inc

Gesloten

SectorGezondheidszorg

94.22 1.08

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

93.92

Max

94.54

Belangrijke statistieken
By Trading Economics
Inkomsten	78M 231M
Verkoop	-76M 2B
K/W Sectorgemiddelde	23.514 80.03
EPS	1.9
Dividendrendement	0.98
Winstmarge	11.552
Werknemers	17,000
EBITDA	63M 638M

Aanbevelingen
By TipRanks
Aanbevelingen	Neutraal
12 Maanden Prognose	+9.65% upside

Dividenden
By Dow Jones
Dividendrendement Sectorgemiddelde	0.98% 2.29%

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-1B 19B
Vorige openingsprijs	93.14
Vorige sluitingsprijs	94.22

Nieuwssentiment

By Acuity

54%

46%

299 / 374 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

92.27 / 100.88 Steun & Weerstand

Zimmer Biomet Holdings Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

5 nov 2025, 19:38 UTC

Winsten

This Healthcare Stock Is the Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

5 nov 2025, 17:00 UTC

Winsten

This Healthcare Stock Is Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

Peer Vergelijking

Prijswijziging

Zimmer Biomet Holdings Inc Prognose

Koersdoel

By TipRanks

9.65% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 103.38 USD 9.65%

Hoogste 130 USD

Laagste 88 USD

Gebaseerd op 19 Wall Street-analisten die 12-maands prijsdoelen bieden voor Zimmer Biomet Holdings Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

19 ratings

Buy

Hold

Sell

Gebaseerd op 19 analisten die aandelenratings hebben gegeven aan Zimmer Biomet Holdings Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

92.27 / 100.88Steun & Weerstand

Recent bearish events outweigh bullish events.

All events are bearish.

Sentiment

By Acuity

299 / 374 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.